Atomic Structure and Biochemical Characterization of an RNA Endonuclease in the N Terminus of Andes Virus L Protein

PLoS Pathogens

Volumn 12, Issue 6, 2016, Pages

  Fernández García, Yaiza ^a,b   Reguera, Juan ^c   Busch, Carola ^a   Witte, Gregor ^d   Sánchez Ramos, Oliberto ^b   Betzel, Christian ^e   Cusack, Stephen ^c   Günther, Stephan ^a   Reindl, Sophia ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; ENDONUCLEASE; MANGANESE; MUTANT PROTEIN; L PROTEIN, HANTAVIRUS; RNA DIRECTED RNA POLYMERASE; VIRAL PROTEIN;

ANDES VIRUS; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ESCHERICHIA COLI; LIGAND BINDING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STABILITY; X RAY ANALYSIS; AMINO ACID SEQUENCE; CHEMISTRY; ENZYMOLOGY; HANTAVIRUS; METABOLISM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; ENDONUCLEASES; HANTAVIRUS; PROTEIN CONFORMATION; PROTEIN STABILITY; RNA REPLICASE; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PROTEINS;

EID: 84978897524     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005635     Document Type: Article

References (58)

1. Macneil A, Nichol ST, Spiropoulou CF, Hantavirus pulmonary syndrome. Virus Res. 2011;162(1–2):138–47. doi: 10.1016/j.virusres.2011.09.01721945215
2. Jonsson CB, Figueiredo LT, Vapalahti O, A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010;23(2):412–41. doi: 10.1128/CMR.00062-0920375360
3. Manigold T, Vial P, Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med Wkly. 2014;144:w13937. doi: 10.4414/smw.2014.1393724652684
4. Schountz T, Prescott J, Hantavirus immunology of rodent reservoirs: current status and future directions. Viruses. 2014;6(3):1317–35. doi: 10.3390/v603131724638205
5. Medina RA, Torres-Perez F, Galeno H, Navarrete M, Vial PA, Palma RE, et al. Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile. J Virol. 2009;83(6):2446–59. doi: 10.1128/JVI.01057-0819116256
6. Wells RM, Young J, Williams RJ, Armstrong LR, Busico K, Khan AS, et al. Hantavirus transmission in the United States. Emerg Infect Dis. 1997;3(3):361–5. 9284382
7. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis. 2005;11(12):1848–53. 16485469
8. Hepojoki J, Strandin T, Lankinen H, Vaheri A, Hantavirus structure—molecular interactions behind the scene. J Gen Virol. 2012;93(Pt 8):1631–44. doi: 10.1099/vir.0.042218-022622328
9. Kukkonen SK, Vaheri A, Plyusnin A, L protein, the RNA-dependent RNA polymerase of hantaviruses. Arch Virol. 2005;150(3):533–56. 15503219
10. Cimica V, Dalrymple NA, Roth E, Nasonov A, Mackow ER, An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein. MBio. 2014;5(1).
11. Jaaskelainen KM, Kaukinen P, Minskaya ES, Plyusnina A, Vapalahti O, Elliott RM, et al. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol. 2007;79(10):1527–36. 17705180
12. Cheng E, Mir MA, Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching. J Virol. 2012;86(18):10173–85. doi: 10.1128/JVI.05560-1122787213
13. Garcin D, Lezzi M, Dobbs M, Elliott RM, Schmaljohn C, Kang CY, et al. The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol. 1995;69(9):5754–62. 7637020
14. Decroly E, Ferron F, Lescar J, Canard B, Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol. 2012;10(1):51–65.
15. Plotch SJ, Bouloy M, Ulmanen I, Krug RM, A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell. 1981;23(3):847–58. 6261960
16. Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, Baudin F, et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature. 2009;458(7240):914–8. doi: 10.1038/nature0774519194459
17. Pflug A, Guilligay D, Reich S, Cusack S, Structure of influenza A polymerase bound to the viral RNA promoter. Nature. 2014;516(7531):355–60. doi: 10.1038/nature1400825409142
18. Guilligay D, Tarendeau F, Resa-Infante P, Coloma R, Crepin T, Sehr P, et al. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol. 2008;15(5):500–6. doi: 10.1038/nsmb.142118454157
19. Reich S, Guilligay D, Pflug A, Malet H, Berger I, Crepin T, et al. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature. 2014;516(7531):361–6. doi: 10.1038/nature1400925409151
20. Reguera J, Weber F, Cusack S, Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog. 2010;6(9):e1001101. doi: 10.1371/journal.ppat.100110120862319
21. Morin B, Coutard B, Lelke M, Ferron F, Kerber R, Jamal S, et al. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog. 2010;6(9):e1001038. doi: 10.1371/journal.ppat.100103820862324
22. Wallat GD, Huang Q, Wang W, Dong H, Ly H, Liang Y, et al. High-resolution structure of the N-terminal endonuclease domain of the Lassa virus L polymerase in complex with magnesium ions. PLoS One. 2014;9(2):e87577. doi: 10.1371/journal.pone.008757724516554
23. Gerlach P, Malet H, Cusack S, Reguera J, Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter. Cell. 2015;161(6):1267–79. doi: 10.1016/j.cell.2015.05.00626004069
24. Fudo S, Yamamoto N, Nukaga M, Odagiri T, Tashiro M, Neya S, et al. Structural and computational study on inhibitory compounds for endonuclease activity of influenza virus polymerase. Bioorg Med Chem. 2015;23(17):5466–75. doi: 10.1016/j.bmc.2015.07.04626252962
25. Hsu JT, Yeh JY, Lin TJ, Li ML, Wu MS, Hsieh CF, et al. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus. Antimicrob Agents Chemother. 2012;56(2):647–57. doi: 10.1128/AAC.00125-1121930871
26. Kowalinski E, Zubieta C, Wolkerstorfer A, Szolar OH, Ruigrok RW, Cusack S, Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase. PLoS Pathog. 2012;8(8):e1002831. doi: 10.1371/journal.ppat.100283122876177
27. Kuzuhara T, Iwai Y, Takahashi H, Hatakeyama D, Echigo N, Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Curr. 2009;1:RRN1052. 20025206
28. Nakazawa M, Kadowaki SE, Watanabe I, Kadowaki Y, Takei M, Fukuda H, PA subunit of RNA polymerase as a promising target for anti-influenza virus agents. Antiviral Res. 2008;78(3):194–201. doi: 10.1016/j.antiviral.2007.12.01018258312
29. Pala N, Stevaert A, Dallocchio R, Dessi A, Rogolino D, Carcelli M, et al. Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors. ACS Med Chem Lett. 2015;6(8):866–71. doi: 10.1021/acsmedchemlett.5b0010926288686
30. Parkes KE, Ermert P, Fassler J, Ives J, Martin JA, Merrett JH, et al. Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors. J Med Chem. 2003;46(7):1153–64. 12646026
31. Sagong HY, Bauman JD, Patel D, Das K, Arnold E, LaVoie EJ, Phenyl substituted 4-hydroxypyridazin-3(2H)-ones and 5-hydroxypyrimidin-4(3H)-ones: inhibitors of influenza A endonuclease. J Med Chem. 2014;57(19):8086–98. doi: 10.1021/jm500958x25225968
32. Shibagaki Y, Ikuta N, Iguchi S, Takaki K, Watanabe S, Kaihotsu M, et al. An efficient screening system for influenza virus cap-dependent endonuclease inhibitors. J Virol Methods. 2014;202:8–14. doi: 10.1016/j.jviromet.2014.02.00524613941
33. Tomassini J, Selnick H, Davies ME, Armstrong ME, Baldwin J, Bourgeois M, et al. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob Agents Chemother. 1994;38(12):2827–37. 7695269
34. Tomassini JE, Davies ME, Hastings JC, Lingham R, Mojena M, Raghoobar SL, et al. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob Agents Chemother. 1996;40(5):1189–93. 8723464
35. DuBois RM, Slavish PJ, Baughman BM, Yun MK, Bao J, Webby RJ, et al. Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease. PLoS Pathog. 2012;8(8):e1002830. doi: 10.1371/journal.ppat.100283022876176
36. Cheng E, Wang Z, Mir MA, Interaction between hantavirus nucleocapsid protein (N) and RNA-dependent RNA polymerase (RdRp) mutants reveals the requirement of an N-RdRp interaction for viral RNA synthesis. J Virol. 2014;88(15):8706–12. doi: 10.1128/JVI.00405-1424850733
37. Heinemann P, Schmidt-Chanasit J, Gunther S, The N terminus of Andes virus L protein suppresses mRNA and protein expression in mammalian cells. J Virol. 2013;87(12):6975–85. doi: 10.1128/JVI.00043-1323576516
38. Ericsson UB, Hallberg BM, Detitta GT, Dekker N, Nordlund P, Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem. 2006;357(2):289–98. 16962548
39. Reguera J, Gerlach P, Rosenthal M, Gaudon S, Coscia F, Guenther S, et al. Comparative structural and functional analysis of bunya- and arenavirus cap-snatching endonucleases. co-submission to Plos Pathogens. 2016.
40. Holm L, Kaariainen S, Wilton C, Plewczynski D, Using Dali for structural comparison of proteins. Curr Protoc Bioinformatics. 2006;Chapter 5:Unit 5
41. Berrow NS, Alderton D, Sainsbury S, Nettleship J, Assenberg R, Rahman N, et al. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Research. 2007;35(6).
42. Hass M, Lelke M, Busch C, Becker-Ziaja B, Gunther S, Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome. J Virol. 2008;82(20):10207–17. doi: 10.1128/JVI.00220-0818667512
43. Battye TGG, Kontogiannis L, Johnson O, Powell HR, Leslie AGW, iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallographica Section D-Biological Crystallography. 2011;67:271–81.
44. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ, Phaser crystallographic software. J Appl Crystallogr. 2007;40(Pt 4):658–74. 19461840
45. Emsley P, Lohkamp B, Scott WG, Cowtan K, Features and development of Coot. Acta Crystallographica Section D-Biological Crystallography. 2010;66:486–501.
46. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):213–21. doi: 10.1107/S090744490905292520124702
47. Painter J, Merritt EA, Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr. 2006;62(Pt 4):439–50. 16552146
48. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12. 15264254
49. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA, Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A. 2001;98(18):10037–41. 11517324
50. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, et al. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 2007;35(Web Server issue):W522–5. 17488841
51. Blanchet CE, Spilotros A, Schwemmer F, Graewert MA, Kikhney A, Jeffries CM, et al. Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY). J Appl Crystallogr. 2015;48(Pt 2):431–43. 25844078
52. Petoukhov MV, Franke D, Shkumatov AV, Tria G, Kikhney AG, Gajda M, et al. New developments in the program package for small-angle scattering data analysis. J Appl Crystallogr. 2012;45(Pt 2):342–50. 25484842
53. Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI, PRIMUS: a Windows PC-based system for small-angle scattering data analysis. Journal of Applied Crystallography. 2003;36:1277–82.
54. Svergun DI, Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J Appl Crystallogr. 1992;25:495–503.
55. Volkov VV, Svergun DI, Uniqueness of ab initio shape determination in small-angle scattering. Journal of Applied Crystallography. 2003;36:860–4.
56. Kozin MB, Svergun DI, Automated matching of high- and low-resolution structural models. Journal of Applied Crystallography. 2001;34:33–41.
57. Schneider CA, Rasband WS, Eliceiri KW, NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5. 22930834
58. Svergun D, Barberato C, Koch MHJ, CRYSOL—A program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. Journal of Applied Crystallography. 1995;28:768–73.